Riociguat in systemic sclerosis: challenges in crossing the bridge from bench to bedside
Lancet Rheumatol
.
2023 Nov;5(11):e641-e643.
doi: 10.1016/S2665-9913(23)00271-0.
Author
Jeska K de Vries-Bouwstra
1
Affiliation
1
Department of Rheumatology, Leiden University Medical Center, PO Box 9600, 2300 ZA Leiden, Netherlands. Electronic address: j.k.de_vries-bouwstra@lumc.nl.
PMID:
38251528
DOI:
10.1016/S2665-9913(23)00271-0
No abstract available
MeSH terms
Humans
Pyrazoles* / therapeutic use
Pyrimidines / therapeutic use
Scleroderma, Systemic* / drug therapy
Substances
riociguat
Pyrazoles
Pyrimidines